{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T22:05:06Z","timestamp":1794089106727,"version":"4.8.0"},"reference-count":44,"publisher":"BMJ","issue":"2","license":[{"start":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T00:00:00Z","timestamp":1771545600000},"content-version":"unspecified","delay-in-days":19,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2026,2,5]]},"published-print":{"date-parts":[[2026,2]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Accurate estimates of the burden of vaccine-preventable community-acquired pneumonia (CAP) hospitalisations both overall and due to the most frequent and vaccine-preventable pathogens are needed to inform the use of respiratory vaccines in adults.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design and setting<\/jats:title>\n                    <jats:p>\n                      This was a prospective, population-based CAP surveillance study at three hospitals in Germany. All patients admitted with clinically suspected CAP were tested for\n                      <jats:italic>Streptococcus pneumoniae<\/jats:italic>\n                      using urine antigen tests and for respiratory syncytial virus (RSV), influenza virus and SARS-CoV-2 using multiplex PCR from nasopharyngeal swabs. Incidence rate calculations for all-cause CAP were based on eligible patients, regardless of enrolment status.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Participants<\/jats:title>\n                    <jats:p>Individuals admitted to study hospitals within the surveillance period with suspected or confirmed diagnosis of pneumonia who provided informed consent.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Outcome measures<\/jats:title>\n                    <jats:p>Radiologically confirmed (RAD) CAP.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Active surveillance between 1 January 2021 and 30 June 2023 identified at the three study sites 4319 adults with RAD-CAP that met eligibility criteria, of which 1479 (34.2%) were enrolled and included in the analysis for pathogen distribution. The main reason for non-enrolment was the inability to provide informed consent. Incidence estimates were based on 1254 study-eligible individuals admitted at the largest study site. SARS-CoV-2,\n                      <jats:italic>S. pneumoniae<\/jats:italic>\n                      , RSV or influenza were identified in 36.5%, 9.1%, 3.7% and 1.8% of patients with RAD-CAP, respectively. Serotypes included in the 20-valent pneumococcal conjugate vaccine were detected in 6.9% of RAD-CAP and 76.0% of pneumococcal CAP. The overall adjusted annual incidence of all-cause RAD-CAP over the study period was 490\/100 000 (95% CI 461 to 521). The incidence of pneumococcal and RSV-related RAD-CAP increased 8.6-fold and 10.0-fold over the study period, resulting in an incidence of 60\/100 000 (95% CI 45 to 75) and 30\/100 000 (95% CI 19 to 41) in 2022\/2023, respectively, while SARS-CoV-2 related RAD-CAP declined by 70% to 97\/100 000 (95% CI 78 to 116).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      Active pneumonia surveillance reported a high burden of RAD-CAP hospitalisations in Germany, especially among older adults. The resurgence of CAP due to RSV,\n                      <jats:italic>S. pneumoniae<\/jats:italic>\n                      or influenza, alongside maintained activity of SARS-CoV-2, was associated with an overall increase of RAD-CAP among adults.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2025-109621","type":"journal-article","created":{"date-parts":[[2026,2,22]],"date-time":"2026-02-22T18:35:30Z","timestamp":1771785330000},"page":"e109621","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":3,"title":["Incidence of all-cause and vaccine-preventable, radiologically confirmed community-acquired pneumonia in hospitalised adults in Germany: a multicentre surveillance study (2021\u20132023)"],"prefix":"10.1136","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0821-9202","authenticated-orcid":false,"given":"Christian","family":"Theilacker","sequence":"first","affiliation":[{"name":"Pfizer Vaccines, Pfizer Inc, Collegeville, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2999-6131","authenticated-orcid":false,"given":"Stefan","family":"Hagel","sequence":"additional","affiliation":[{"name":"Institute for Infectious Diseases and Infection Control, Jena University Hospital, Jena, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliane","family":"Ankert","sequence":"additional","affiliation":[{"name":"Institute for Infectious Diseases and Infection Control, Jena University Hospital, Jena, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Schwarz","sequence":"additional","affiliation":[{"name":"Pfizer Vaccines, Pfizer Inc, Collegeville, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-9024-7169","authenticated-orcid":false,"given":"Alexander C","family":"Tinworth","sequence":"additional","affiliation":[{"name":"Pfizer Vaccines, Pfizer Inc, Collegeville, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christof","family":"von Eiff","sequence":"additional","affiliation":[{"name":"Vaccines Germany, Pfizer Pharma GmbH, Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralf-Dirk","family":"Wolf","sequence":"additional","affiliation":[{"name":"Vaccines Germany, Pfizer Pharma GmbH, Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Vietri","sequence":"additional","affiliation":[{"name":"Pfizer Vaccines, Pfizer Inc, Collegeville, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Wang","sequence":"additional","affiliation":[{"name":"Pfizer Vaccines, Pfizer Inc, Collegeville, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaijie","family":"Pan","sequence":"additional","affiliation":[{"name":"Pfizer Vaccines, Pfizer Inc, Collegeville, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradford D","family":"Gessner","sequence":"additional","affiliation":[{"name":"Pfizer Vaccines, Pfizer Inc, Collegeville, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8157-2753","authenticated-orcid":false,"given":"Mathias W","family":"Pletz","sequence":"additional","affiliation":[{"name":"Institute for Infectious Diseases and Infection Control, Jena University Hospital, Jena, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,2,22]]},"reference":[{"key":"2026022210351703000_16.2.e109621.1","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1016\/S0140-6736(24)00757-8","article-title":"Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990\u20132021: a systematic analysis for the Global Burden of Disease Study 2021","volume":"403","author":"Ferrari","year":"2024","journal-title":"The Lancet"},{"key":"2026022210351703000_16.2.e109621.2","unstructured":"Destatis . Gestorbene: deutschland, jahre, todesursachen, geschlecht, altersgruppen: deutsches statistisches bundesamt. 2023. Available: https:\/\/www-genesis.destatis.de\/datenbank\/online\/statistic\/23211\/table\/23211-0002"},{"key":"2026022210351703000_16.2.e109621.3","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2024.14796"},{"key":"2026022210351703000_16.2.e109621.4","doi-asserted-by":"crossref","first-page":"105694","DOI":"10.1016\/j.jcv.2024.105694","article-title":"Resurgence of common respiratory viruses in patients with community-acquired pneumonia (CAP)-A prospective multicenter study","volume":"173","author":"D\u00e4hne","year":"2024","journal-title":"J Clin Virol"},{"key":"2026022210351703000_16.2.e109621.5","doi-asserted-by":"crossref","DOI":"10.1017\/S0950268822001182","article-title":"Clinical and economic burden of pneumococcal disease among individuals aged 16 years and older in Germany","volume":"150","author":"Deb","year":"2022","journal-title":"Epidemiol Infect"},{"key":"2026022210351703000_16.2.e109621.6","doi-asserted-by":"publisher","DOI":"10.1136\/thx.2008.109785"},{"key":"2026022210351703000_16.2.e109621.7","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.rmed.2016.10.015","article-title":"Burden and risk factors of ambulatory or hospitalized CAP: A population based cohort study","volume":"121","author":"Kolditz","year":"2016","journal-title":"Respir Med"},{"key":"2026022210351703000_16.2.e109621.8","doi-asserted-by":"crossref","DOI":"10.1186\/s12879-015-1162-y","article-title":"Rates of pneumonia among children and adults with chronic medical conditions in Germany","volume":"15","author":"Pelton","year":"2015","journal-title":"BMC Infect Dis"},{"key":"2026022210351703000_16.2.e109621.9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2007.04.355"},{"key":"2026022210351703000_16.2.e109621.10","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0253118","article-title":"Population-based incidence and mortality of community-acquired pneumonia in Germany","volume":"16","author":"Theilacker","year":"2021","journal-title":"PLoS One"},{"key":"2026022210351703000_16.2.e109621.11","first-page":"195","article-title":"The effects of the COVID-19 pandemic on community respiratory virus activity","volume":"21","author":"Chow","year":"2023","journal-title":"Nat Rev Microbiol"},{"key":"2026022210351703000_16.2.e109621.12","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1007\/s40121-024-00949-8","article-title":"Best Practices for Identifying Hospitalized Lower Respiratory Tract Infections Using Administrative Data: A Systematic Literature Review of Validation Studies","volume":"13","author":"Hanquet","year":"2024","journal-title":"Infect Dis Ther"},{"key":"2026022210351703000_16.2.e109621.13","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00064-12"},{"key":"2026022210351703000_16.2.e109621.14","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa158"},{"key":"2026022210351703000_16.2.e109621.15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0220453","article-title":"Limited indirect effects of an infant pneumococcal vaccination program in an aging population","volume":"14","author":"van der Linden","year":"2019","journal-title":"PLoS One"},{"key":"2026022210351703000_16.2.e109621.16","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7104a1"},{"key":"2026022210351703000_16.2.e109621.17","unstructured":"Wissenschaftliche Begr\u00fcndung f\u00fcr die Aktualisierung der STIKO-Empfehlungen zur Pneumokokken-Standardimpfung von Personen \u226560 Jahre sowie zur Pneumokokken Indikationsimpfung von Risikogruppe. Epidemiologisches Bulletin 2023;6\u201341."},{"key":"2026022210351703000_16.2.e109621.18","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199701233360402"},{"key":"2026022210351703000_16.2.e109621.19","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.168.13.1465"},{"key":"2026022210351703000_16.2.e109621.20","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1500245"},{"key":"2026022210351703000_16.2.e109621.21","unstructured":"Th\u00fcringer Landesamt f\u00fcr Statistik . Bev\u00f6lkerung der gemeinden, erf\u00fcllenden gemeinden und verwaltungsgemeinschaften am 30.6. Available: https:\/\/statistik.thueringen.de\/datenbank\/TabAnzeige.asp?tabelle=gg000201%7C%7C [Accessed 30 Feb 2024]."},{"key":"2026022210351703000_16.2.e109621.22","doi-asserted-by":"crossref","first-page":"S570","DOI":"10.1093\/infdis\/jiz053","article-title":"Global and Regional Burden of Hospital Admissions for Pneumonia in Older Adults: A Systematic Review and Meta-Analysis","volume":"222","author":"Shi","year":"2020","journal-title":"J Infect Dis"},{"key":"2026022210351703000_16.2.e109621.23","doi-asserted-by":"crossref","DOI":"10.1016\/j.lanepe.2022.100473","article-title":"Incidence of community acquired lower respiratory tract disease in Bristol, UK during the COVID-19 pandemic: A prospective cohort study","volume":"21","author":"Hyams","year":"2022","journal-title":"Lancet Reg Health Eur"},{"key":"2026022210351703000_16.2.e109621.24","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cix647"},{"key":"2026022210351703000_16.2.e109621.25","first-page":"114","article-title":"The Increase in Invasive Bacterial Infections With Respiratory Transmission in Germany, 2022\/2023","volume":"121","author":"Singer","year":"2024","journal-title":"Dtsch Arztebl Int"},{"key":"2026022210351703000_16.2.e109621.26","doi-asserted-by":"crossref","first-page":"e582","DOI":"10.1016\/S2589-7500(23)00108-5","article-title":"Trends in invasive bacterial diseases during the first 2 years of the COVID-19 pandemic: analyses of prospective surveillance data from 30 countries and territories in the IRIS Consortium","volume":"5","author":"Shaw","year":"2023","journal-title":"Lancet Digit Health"},{"key":"2026022210351703000_16.2.e109621.27","doi-asserted-by":"crossref","DOI":"10.3390\/v15040877","article-title":"In-Depth Analysis of the Re-Emergence of Respiratory Syncytial Virus at a Tertiary Care Hospital in Germany in the Summer of 2021 after the Alleviation of Non-Pharmaceutical Interventions Due to the SARS-CoV-2 Pandemic","volume":"15","author":"H\u00f6nemann","year":"2023","journal-title":"Viruses"},{"key":"2026022210351703000_16.2.e109621.28","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(22)00525-4"},{"key":"2026022210351703000_16.2.e109621.29","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1093\/cid\/ciae493","article-title":"Cycles of Susceptibility: Immunity Debt Explains Altered Infectious Disease Dynamics Post-Pandemic","volume":"81","author":"Munro","year":"2026","journal-title":"Clin Infect Dis"},{"key":"2026022210351703000_16.2.e109621.30","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02432-2021","article-title":"A longitudinal analysis of pneumococcal vaccine serotypes in pneumonia patients in Germany","volume":"59","author":"Bahrs","year":"2022","journal-title":"Eur Respir J"},{"key":"2026022210351703000_16.2.e109621.31","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofae727","article-title":"Streptococcus pneumoniae Serotype Distribution Among US Adults Hospitalized With Community-Acquired Pneumonia, 2019-2020","volume":"12","author":"Ramirez","year":"2025","journal-title":"Open Forum Infect Dis"},{"key":"2026022210351703000_16.2.e109621.32","doi-asserted-by":"publisher","DOI":"10.1136\/thorax-2024-221976"},{"key":"2026022210351703000_16.2.e109621.33","doi-asserted-by":"crossref","DOI":"10.1099\/acmi.0.000094","article-title":"Re-validation and update of an extended-specificity multiplex assay for detection of Streptococcus pneumoniae capsular serotype\/serogroup-specific antigen and cell-wall polysaccharide in urine specimens","volume":"2","author":"Eletu","year":"2020","journal-title":"Access Microbiol"},{"key":"2026022210351703000_16.2.e109621.34","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1007\/s40121-023-00805-1","article-title":"Diagnosis of Respiratory Syncytial Virus in Adults Substantially Increases When Adding Sputum, Saliva, and Serology Testing to Nasopharyngeal Swab RT-PCR","volume":"12","author":"Ramirez","year":"2023","journal-title":"Infect Dis Ther"},{"key":"2026022210351703000_16.2.e109621.35","doi-asserted-by":"crossref","first-page":"e126","DOI":"10.1093\/infdis\/jiaf204","article-title":"Detection by Nasopharyngeal Swabs Alone Underestimates Respiratory Syncytial Virus-Related Hospitalization Incidence in Adults: The Multispecimen Study\u2019s Final Analysis","volume":"232","author":"Begier","year":"2025","journal-title":"J Infect Dis"},{"key":"2026022210351703000_16.2.e109621.36","doi-asserted-by":"crossref","first-page":"106440","DOI":"10.1016\/j.jinf.2025.106440","article-title":"Incidence of RSV-related hospitalizations for ARIs, including CAP: Data from the German prospective ThEpiCAP study","volume":"90","author":"Liang","year":"2025","journal-title":"J Infect"},{"key":"2026022210351703000_16.2.e109621.37","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1007\/s40121-024-00951-0","article-title":"Estimated Incidence of Hospitalizations and Deaths Attributable to Respiratory Syncytial Virus Infections Among Adults in Germany Between 2015 and 2019","volume":"13","author":"Polkowska-Kramek","year":"2024","journal-title":"Infect Dis Ther"},{"key":"2026022210351703000_16.2.e109621.38","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.01874-17","article-title":"Accuracy of High-Throughput Nanofluidic PCR-Based Pneumococcal Serotyping and Quantification Assays Using Sputum Samples for Diagnosing Vaccine Serotype Pneumococcal Pneumonia: Analyses by Composite Diagnostic Standards and Bayesian Latent Class Models","volume":"56","author":"Kakiuchi","year":"2018","journal-title":"J Clin Microbiol"},{"key":"2026022210351703000_16.2.e109621.39","doi-asserted-by":"crossref","first-page":"6255","DOI":"10.1016\/j.vaccine.2017.09.048","article-title":"Estimating the full public health value of vaccination","volume":"35","author":"Gessner","year":"2017","journal-title":"Vaccine (Auckl)"},{"key":"2026022210351703000_16.2.e109621.40","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciy993"},{"key":"2026022210351703000_16.2.e109621.41","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1001\/jamainternmed.2022.5472","article-title":"Association of Pneumococcal Conjugate Vaccine Use With Hospitalized Pneumonia in Medicare Beneficiaries 65 Years or Older With and Without Medical Conditions, 2014 to 2017","volume":"183","author":"Kobayashi","year":"2023","journal-title":"JAMA Intern Med"},{"key":"2026022210351703000_16.2.e109621.42","doi-asserted-by":"crossref","first-page":"3352","DOI":"10.1016\/j.vaccine.2019.04.087","article-title":"Pneumococcal epidemiology among us adults hospitalized for community-acquired pneumonia","volume":"37","author":"Isturiz","year":"2019","journal-title":"Vaccine (Auckl)"},{"key":"2026022210351703000_16.2.e109621.43","unstructured":"Robert-Koch-Institut . Impfquoten in Deutschland \u2013 aktuelle Ergebnisse aus dem RKI-Impfquotenmonitoring. Epidemiologisches Bulletin 2024;3\u201310."},{"key":"2026022210351703000_16.2.e109621.44","unstructured":"Destatis . Population: germany, reference date, age, code: 12411-0005 2024. Available: https:\/\/www-genesis.destatis.de\/datenbank\/online\/statistic\/12411\/table\/12411-0005 [Accessed 14 Jan 2025]."}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2025-109621","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,22]],"date-time":"2026-02-22T18:35:34Z","timestamp":1771785334000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2025-109621"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":44,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,2,22]]},"published-print":{"date-parts":[[2026,2]]}},"alternative-id":["10.1136\/bmjopen-2025-109621"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2025-109621","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2]]}}}